Magnetar Financial’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Magnetar Financial’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,811	Closed	-$71K	–	630
2020 Q1	$71K	Sell	18,811 -2,235	-11%	-$9.63K	﹤0.01%	446
2019 Q4	$107K	Buy	+21,046	New	+$111K	﹤0.01%	511

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Magnetar Financial's PGNX Position: Q2 2020 in Review

Magnetar Financial sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 18,811 shares — an estimated $71K sold.

Magnetar Financial first reported a position in PGNX in Q4 2019 and held it in 2 quarters. The position peaked at $107K in Q4 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Magnetar Financial reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Magnetar Financial sold 18,811 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $71K.
Magnetar Financial first reported a position in Progenics Pharmaceuticals Inc in Q4 2019 and held it in 2 quarters.
Magnetar Financial's Progenics Pharmaceuticals Inc position peaked at $107K in Q4 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Magnetar Financial's 13F filing for Q2 2020, filed 14 Aug 2020.